Cell Biotech Overview
- Year Founded
-
1995

- Status
-
Public
- Employees
-
133

- Stock Symbol
-
049960

- Share Price
-
$9.02
- (As of Friday Closing)
Cell Biotech General Information
Description
Cell Biotech Co Ltd is a specialized biotech company. It is engaged in the fermentation and coating technology development as well as manufacturing probiotics and lactic acid bacteria. The key product consists Probiotic DUOLAC, Nutra DUOLAC, LACTOClear, and LAB2PRO. The company distributes its products within domestic market and to overseas markets.
Contact Information
Website
www.cellbiotech.comCorporate Office
- 397, Aegibong-ro
- Wolgot-Myeon
- Gimpo, Gyeonggi 415-872
- South Korea
Corporate Office
- 397, Aegibong-ro
- Wolgot-Myeon
- Gimpo, Gyeonggi 415-872
- South Korea
Cell Biotech Stock Performance
As of 09-May-2025, Cell Biotech’s stock price is $9.02. Its current market cap is $61.7M with 6.84M shares.
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$9.02 | $9.01 | $7.83 - $12.24 | $61.7M | 6.84M | 13.5K | $1.62 |
Cell Biotech Financials Summary
As of 31-Dec-2024, Cell Biotech has a trailing 12-month revenue of $36.6M.
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
---|---|---|---|---|
EV | 7,621 | 7,621 | 10,562 | 24,224 |
Revenue | 36,581 | 36,581 | 41,139 | 39,103 |
EBITDA | 12,043 | 12,043 | 5,863 | 10,051 |
Net Income | 11,086 | 11,086 | 4,821 | 6,409 |
Total Assets | 88,527 | 88,527 | 91,288 | 91,724 |
Total Debt | 690 | 690 | 1,207 | 759 |
Cell Biotech Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Cell Biotech Patents
Cell Biotech Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-4467149-A1 | Composition comprising probiotics for removal of heavy metals | Pending | 18-Jan-2022 | ||
EP-4424168-A1 | Antibacterial composition containing lactobacillus strain culture filtrate | Pending | 29-Oct-2021 | ||
EP-3845632-A1 | Composition for promoting the growth of lactic acid bacteria comprising growth factors | Pending | 02-Jan-2020 | ||
US-20210207077-A1 | Composition for promoting the growth of lactic acid bacteria comprising growth factors | Inactive | 02-Jan-2020 | ||
US-20230392111-A1 | Composition for promoting the growth of lactic acid bacteria comprising growth factors | Active | 02-Jan-2020 | C12N1/20 |
Cell Biotech Signals
Cell Biotech ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile

Pharmaceuticals
Industry
Rank
Percentile

Biotechnology
Subindustry
Rank
Percentile

Cell Biotech FAQs
-
When was Cell Biotech founded?
Cell Biotech was founded in 1995.
-
Where is Cell Biotech headquartered?
Cell Biotech is headquartered in Gimpo, South Korea.
-
What is the size of Cell Biotech?
Cell Biotech has 133 total employees.
-
What industry is Cell Biotech in?
Cell Biotech’s primary industry is Biotechnology.
-
Is Cell Biotech a private or public company?
Cell Biotech is a Public company.
-
What is Cell Biotech’s stock symbol?
The ticker symbol for Cell Biotech is 049960.
-
What is the current stock price of Cell Biotech?
As of 09-May-2025 the stock price of Cell Biotech is $9.02.
-
What is the current market cap of Cell Biotech?
The current market capitalization of Cell Biotech is $61.7M.
-
What is Cell Biotech’s current revenue?
The trailing twelve month revenue for Cell Biotech is $36.6M.
-
What is Cell Biotech’s annual earnings per share (EPS)?
Cell Biotech’s EPS for 12 months was $1.62.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »